Lot GT30-062026-1
30mgFreedom Diagnostics Testing · Tested 2026-06-14 · Accession Nura2606110432

Analytical Standard
Dual Incretin Receptor Agonist Peptide
A synthetic peptide with dual activity at both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors.
Available strength
Bundle & Save
Volume pricing applies automatically to every compound.
Selected price
$60.00
Order within · ships Monday
Orders placed now ship on Monday. Same-day dispatch before 3:00 PM ET · Monday–Friday
Cutoff is calculated in Eastern Time (ET).
Same-day dispatch window
Place an order before the weekday cutoff for same-day dispatch.
Monday–Friday fulfillment
Orders placed after cutoff or during the weekend move to the next business-day dispatch window.
Free shipping on orders of $200+
Insured 2nd Day Air is free when your product total after discounts is $200 or more; otherwise $12. Shipping is shown before order placement.
Synthesized to evaluate incretin-mediated glucose homeostasis and lipid signaling mechanisms in controlled in vitro systems. Verified for analytical identity and high chromatographic purity.
Third-party laboratory verification
Every verified batch on record is listed with the most recent test date first.
Filter by labeled strength
Showing 7 of 7 records.
Lot GT30-062026-1
30mgFreedom Diagnostics Testing · Tested 2026-06-14 · Accession Nura2606110432
Lot GT10-062026-1
Current10mgFreedom Diagnostics Testing · Tested 2026-06-14 · Accession Nura2606110429
Lot GT60-062026-1
60mgFreedom Diagnostics Testing · Tested 2026-06-14 · Accession Nura2606110435
Lot TIR101225J
10mgFreedom Diagnostics Testing · Tested 2025-11-10 · Accession Nura2511100045
Lot TIR101125J
10mgFreedom Diagnostics Testing · Tested 2025-11-10 · Accession Nura2511100044
Lot GLT10823
10mgFreedom Diagnostics Testing · Tested 2025-09-05 · Accession Nura2509040011
Lot GLT30823
30mgFreedom Diagnostics Testing · Tested 2025-09-05 · Accession Nura2509040016